Market closed

Hikma Pharmaceuticals/£HIK

08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX

About Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC, operating under the ticker HIK, is a multinational pharmaceutical company. Founded in 1978 and headquartered in London, UK, it specializes in developing, manufacturing, and marketing both branded and non-branded generic and in-licensed pharmaceutical products. The company operates within the healthcare sector, focusing on a broad range of therapeutic areas.

Ticker

£HIK
Sector
Health Care

Trading on

LSE

Industry

Pharmaceuticals
Headquarters
London, United Kingdom

Employees

9,100
Website
www.hikma.com

HIK Metrics

BasicAdvanced
£4.4B
19.12
£1.04
0.40
£0.79
3.96%

£4.4B

0.4

£21.65

£17.50

338K

£0.79

1.656

0.888

46.13

55.478

55.79%

9.75%

9.40%

12.88%

19.123

1.779

1.94

3.72

14.163

3.96%

10.47%

92.80%

7.55%

-14.13%

14.96%

What the Analysts think about HIK

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Hikma Pharmaceuticals stock.

HIK Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

HIK Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe

Buy £HIK

£

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Hikma Pharmaceuticals stock?

Hikma Pharmaceuticals (HIK) has a market cap of £4.4B as of January 15, 2025.

What is the P/E ratio for Hikma Pharmaceuticals stock?

The price to earnings (P/E) ratio for Hikma Pharmaceuticals (HIK) stock is 19.12 as of January 15, 2025.

Does Hikma Pharmaceuticals stock pay dividends?

Yes, the Hikma Pharmaceuticals (HIK) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is £0.79 and the yield is 3.96%. Hikma Pharmaceuticals has a payout ratio of 55.79% on a trailing twelve-month basis.

When is the next Hikma Pharmaceuticals dividend payment date?

The next Hikma Pharmaceuticals (HIK) dividend payment date is unconfirmed.

What is the beta indicator for Hikma Pharmaceuticals?

Hikma Pharmaceuticals (HIK) has a beta rating of 0.4. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.